Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesCan healthy, older, nonosteoporotic men benefit from calcium supplementation?
Current Osteoporosis Reports, 09/10/09
Lee C – This trial offers supportive evidence on the benefi cial effect of 1200 mg/day of calcium citrate on BMD when given in divided doses in older, non–osteoporotic men. Although increases in BMD were shown at both the hip and lumbar spine, the increase was more rapid at the lumbar spine. In contrast, 600 mg/day of calcium citrate failed to demonstrate any notable improvements in BMD as compared with placebo. Yet, the levels of calcium intake appeared to correspond with dose–related reductions in PTH, P1NP, and ALP activity in a subgroup of subjects whose serum levels were measured. The absence of an improvement in BMD with supplementation of 600 mg/day of calcium citrate, despite reductions in PTH, P1NP, and ALP activity, is not entirely inconsistent with previous findings.
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Sponsor
Article Search
Sponsor